IPO
The Suzhou-based cancer-drug maker has been discussing a valuation of more than $1 billion.
The company plans to offer 2.73 million shares priced between $10 and $12 each.
The listing of a minority of the unit, which makes X-ray and MRI machines, is set to take place in the first half of 2018.
Three biotech companies want to start out the new year with a new start.
A look at what three ex-Genentech employees have accomplished at Denali so far.
With the raise, the company’s market valuation is currently $1.7B.
Siemens Healthineers, the German industrial conglomerate’s largest and most profitable division, is worth roughly $47.49 billion.
Denali plans to make a $100M IPO under the symbol DNLI.
The public listing is expected to value the business at around $46 billion.
Moderna CEO said the company was not likely to float its initial public offering until the company has solid data on its lead mRNA treatment.
PRESS RELEASES